Literature DB >> 2942776

The role of complement and its receptor in the elimination of immune complexes.

J A Schifferli, Y C Ng, D K Peters.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2942776     DOI： 10.1056/NEJM198608213150805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  96 in total

1.  Analysis of human C4A and C4B binding to an immune complex in serum.

Authors:  B D Reilly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  Influence of serotype of group B streptococci on C3 degradation.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

3.  A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.

Authors:  M B Fasano; J A Winkelstein; T LaRosa; W B Bias; R H McLean
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

5.  Selective IgA deficiency associated with glomerulonephritis and oligoarthritis.

Authors:  J P Camilleri; R H Moore; D F Griffiths; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

6.  Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species.

Authors:  E V Ruggieri; P J Bugelski; J M Kaplan; D Everitt; J Lipani; D K Jorkasky; S C Boike; F DeClement; F D Moore; D J Herzyk
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

7.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

8.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

9.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

10.  The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Authors:  M Tonoli; K A Davies; P J Norsworthy; J Cohen; M J Walport
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.